Lisi S.A. (LSIIF)
For informational purposes only. Not financial advice. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.
Lisi S.A. (LSIIF) with AI Score 47/100 (Weak). Lisi S. A. is a global industrial company specializing in the design and manufacture of high-value-added assembly and component solutions. Market cap: 0, Sector: Industrials.
Last analyzed: Mar 16, 2026Lisi S.A. (LSIIF) Industrial Operations Profile
Lisi S.A., founded in 1777, provides assembly and component solutions for the aerospace, automotive, and medical industries internationally. With a market capitalization of $2.69 billion and a P/E ratio of 16.14, Lisi operates through three divisions, focusing on high-value-added components and assemblies.
Investment Thesis
Lisi S.A. presents a compelling investment case based on its diversified exposure to the aerospace, automotive, and medical sectors. The company's focus on high-value-added components and assemblies provides a degree of resilience against economic cycles. With a market capitalization of $2.69 billion and a profit margin of 7.9%, Lisi demonstrates financial stability. Key growth catalysts include the recovery of the aerospace industry, increasing demand for advanced automotive components, and the expanding market for medical implants. Potential risks include fluctuations in raw material prices and competition from other industrial manufacturers. The company's dividend yield is 0.79%.
Based on FMP financials and quantitative analysis
Key Highlights
- Market Cap of $2.69B indicates substantial company size and investor confidence.
- P/E ratio of 16.14 suggests the company is reasonably valued compared to its earnings.
- Profit Margin of 7.9% reflects the company's ability to generate profit from its revenue.
- Gross Margin of 31.6% demonstrates efficient cost management in production.
- Dividend Yield of 0.79% provides a modest return to investors.
Competitors & Peers
Strengths
- Diversified exposure to aerospace, automotive, and medical industries.
- Established relationships with major customers.
- Proprietary technology and expertise.
- Strong financial performance.
Weaknesses
- Exposure to cyclical industries.
- Reliance on raw material prices.
- Competition from other industrial manufacturers.
- OTC market trading can impact liquidity.
Catalysts
- Upcoming: Recovery in the aerospace industry leading to increased demand for LISI Aerospace components.
- Ongoing: Automotive electrification driving demand for LISI Automotive's lightweight fastening solutions.
- Ongoing: Innovation in medical devices boosting demand for LISI Medical's implants and instruments.
- Upcoming: Potential strategic acquisitions to expand product portfolio and geographic reach.
- Ongoing: Operational efficiency improvements to enhance profitability and competitiveness.
Risks
- Potential: Economic downturn impacting demand in the aerospace, automotive, and medical industries.
- Potential: Fluctuations in raw material prices increasing production costs.
- Potential: Increased competition from other industrial manufacturers.
- Ongoing: Regulatory changes affecting the aerospace, automotive, and medical industries.
- Ongoing: OTC market trading can impact liquidity and increase volatility.
Growth Opportunities
- Aerospace Recovery: The resurgence of the aerospace industry, driven by increased air travel and aircraft orders, presents a significant growth opportunity for LISI Aerospace. As airlines expand their fleets and aircraft manufacturers ramp up production, demand for Lisi's aerospace components, including fasteners and structural parts, is expected to increase. This growth is supported by long-term contracts and the company's established relationships with major aerospace players. The timeline for this growth is ongoing, with a projected market size increase of 5-7% annually.
- Automotive Electrification: The shift towards electric vehicles (EVs) and hybrid electric vehicles (HEVs) is creating new opportunities for LISI Automotive. The company's expertise in developing lightweight and high-strength fastening solutions is well-suited for the EV market, where weight reduction and performance are critical. Lisi can capitalize on the growing demand for EV components by expanding its product portfolio and targeting new customers in the EV supply chain. This growth is anticipated to accelerate over the next 3-5 years, with the EV market projected to grow at a CAGR of 20-30%.
- Medical Device Innovation: The medical device industry is characterized by continuous innovation and technological advancements. LISI Medical can drive growth by investing in research and development to develop new and improved medical implants and instruments. The company can also expand its presence in emerging markets, where demand for medical devices is growing rapidly. This growth is expected to continue over the next decade, driven by an aging population and increasing healthcare spending. The global medical device market is projected to reach $600 billion by 2030.
- Strategic Acquisitions: Lisi S.A. can pursue strategic acquisitions to expand its product portfolio, geographic reach, and technological capabilities. Acquisitions can provide access to new markets, customers, and technologies, accelerating the company's growth and strengthening its competitive position. Lisi can target companies in the aerospace, automotive, and medical industries that offer complementary products or services. The timeline for acquisitions is opportunistic, depending on market conditions and available targets. Successful acquisitions can contribute significantly to Lisi's long-term growth.
- Operational Efficiency Improvements: Lisi S.A. can improve its profitability and competitiveness by implementing operational efficiency improvements across its three divisions. This includes streamlining manufacturing processes, reducing waste, and optimizing supply chain management. By improving its operational efficiency, Lisi can lower its costs, increase its margins, and enhance its customer service. The timeline for operational efficiency improvements is ongoing, with continuous efforts to identify and implement best practices. These improvements can contribute to a 1-2% increase in profit margins over the next 2-3 years.
Opportunities
- Aerospace recovery.
- Automotive electrification.
- Medical device innovation.
- Strategic acquisitions.
Threats
- Economic downturn.
- Fluctuations in raw material prices.
- Increased competition.
- Regulatory changes.
Competitive Advantages
- High barriers to entry due to stringent quality standards and regulatory requirements.
- Established relationships with major customers in the aerospace, automotive, and medical industries.
- Proprietary technology and expertise in designing and manufacturing high-value-added components.
- Diversified exposure to multiple industries, reducing reliance on any single sector.
About LSIIF
Lisi S.A., tracing its origins back to 1777, has evolved from GFI Industries into a prominent provider of assembly and component solutions. Headquartered in Belfort, France, Lisi operates globally, serving the aerospace, automotive, and medical industries. The company's structure is organized into three divisions: LISI Aerospace, LISI Automotive, and LISI Medical. LISI Aerospace provides critical components such as titanium nuts, lightning strike protection, and complex engine parts for the LEAP engine and Airbus aircraft. LISI Automotive delivers fastening and assembly solutions for automotive systems, including braking, safety, and interior components. LISI Medical focuses on designing and manufacturing implants and instruments for orthopedic and surgical applications. Lisi S.A. is a subsidiary of Compagnie Industrielle De Delle S.A.
What They Do
- Designs and manufactures assembly and component solutions.
- Serves the aerospace industry with titanium nuts, lightning strike protection, and engine components.
- Provides fastening and assembly solutions for the automotive industry.
- Offers medical implants and instruments for orthopedic and surgical applications.
- Engages in designing and modeling, prototypes, and pre-series production.
- Provides solutions for weight reduction and optimizing assemblies in the automotive sector.
- Offers spinal and trauma implants, such as connectors, screws, cages, and plates for medical use.
Business Model
- Manufacturing and selling high-value-added components and assemblies to aerospace, automotive, and medical industries.
- Providing customized solutions tailored to specific customer needs.
- Generating revenue through long-term contracts and recurring orders.
- Investing in research and development to develop new and innovative products.
Industry Context
Lisi S.A. operates in the industrial sector, specifically within the aerospace & defense, automotive, and medical industries. These sectors are characterized by high barriers to entry, stringent quality standards, and long-term contracts. The aerospace industry is experiencing a recovery, driven by increased air travel and aircraft production. The automotive industry is undergoing a transformation with the rise of electric vehicles and advanced driver-assistance systems (ADAS). The medical industry is growing due to an aging population and advancements in medical technology. Lisi competes with companies like AUTLF, CHYCY, CMGMF, CMGMY, and IRRHF.
Key Customers
- Aerospace companies: Airbus, Boeing, and other aircraft manufacturers.
- Automotive companies: Major automotive OEMs and suppliers.
- Medical device companies: Hospitals, clinics, and surgeons.
Financials
Chart & Info
Lisi S.A. (LSIIF) stock price: Price data unavailable
Latest News
-
European Stocks Estimated To Be Trading Below Fair Value In February 2026
Simply Wall St. · Feb 5, 2026
Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for LSIIF.
Price Targets
Wall Street price target analysis for LSIIF.
MoonshotScore
What does this score mean?
The MoonshotScore rates LSIIF's growth potential on a scale of 0-100 across multiple factors including innovation, market disruption, financial health, and momentum.
Leadership: Emmanuel Viellard
Unknown
Information about Emmanuel Viellard's background is not available in the provided context. Therefore, details regarding his career history, education, previous roles, and credentials cannot be provided. More information is needed to complete this section.
Track Record: Information about Emmanuel Viellard's track record is not available in the provided context. Therefore, details regarding his key achievements, strategic decisions, and company milestones under his leadership cannot be provided. More information is needed to complete this section.
LSIIF OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, indicating that Lisi S.A. may not meet the minimum financial standards required for higher tiers like OTCQX or OTCQB. Companies in this tier may have limited reporting requirements, potentially leading to less transparency for investors. Trading on this tier is often associated with higher risks due to the lack of stringent listing requirements and regulatory oversight compared to major exchanges like the NYSE or NASDAQ.
- OTC Tier: OTC Other
- Disclosure Status: Unknown
- Limited liquidity due to lower trading volumes on the OTC market.
- Less stringent reporting requirements may result in less transparency.
- Higher price volatility compared to stocks listed on major exchanges.
- Potential for wider bid-ask spreads, increasing transaction costs.
- Risk of delisting or suspension from the OTC market.
- Verify the company's financial statements and SEC filings (if any).
- Research the company's management team and their experience.
- Assess the company's business model and competitive landscape.
- Evaluate the company's growth prospects and potential risks.
- Monitor news and announcements related to the company.
- Consult with a financial advisor before investing.
- Understand the risks associated with OTC trading.
- The company has been in operation since 1777, indicating a long history.
- Lisi S.A. serves reputable customers in the aerospace, automotive, and medical industries.
- The company has a market capitalization of $2.69 billion, suggesting a substantial business.
- Lisi S.A. operates through three distinct divisions, demonstrating diversification.
- The company is a subsidiary of Compagnie Industrielle De Delle S.A.
What Investors Ask About Lisi S.A. (LSIIF)
What does Lisi S.A. do?
Lisi S.A. is a global industrial company that designs, manufactures, and sells high-value-added assembly and component solutions for the aerospace, automotive, and medical industries. The company operates through three divisions: LISI Aerospace, which provides critical components for aircraft; LISI Automotive, which offers fastening and assembly solutions for automotive systems; and LISI Medical, which focuses on designing and manufacturing implants and instruments for orthopedic and surgical applications. Lisi's products are used in a wide range of applications, from aircraft engines to automotive safety systems to medical implants.
What do analysts say about LSIIF stock?
AI analysis is pending for LSIIF. Therefore, a summary of analyst consensus, key valuation metrics, and growth considerations cannot be provided at this time. Investors should conduct their own due diligence and consult with a financial advisor before making any investment decisions. Further information is needed to complete this section.
What are the main risks for LSIIF?
Lisi S.A. faces several risks, including exposure to cyclical industries, fluctuations in raw material prices, increased competition, regulatory changes, and OTC market trading. A downturn in the aerospace, automotive, or medical industries could negatively impact demand for Lisi's products. Fluctuations in raw material prices, such as titanium and steel, could increase production costs. Increased competition from other industrial manufacturers could erode Lisi's market share. Regulatory changes in the aerospace, automotive, and medical industries could increase compliance costs. OTC market trading can impact liquidity and increase volatility.
What are the key factors to evaluate for LSIIF?
Lisi S.A. (LSIIF) currently holds an AI score of 47/100, indicating low score. Key strength: Diversified exposure to aerospace, automotive, and medical industries.. Primary risk to monitor: Potential: Economic downturn impacting demand in the aerospace, automotive, and medical industries.. This is not financial advice.
How frequently does LSIIF data refresh on this page?
LSIIF prices update in real time during U.S. market hours (9:30 AM-4:00 PM ET, weekdays). Fundamentals refresh after quarterly or annual filings. Analyst ratings and AI insights update daily. News is aggregated continuously from financial sources.
What has driven LSIIF's recent stock price performance?
Recent price movement in Lisi S.A. (LSIIF) can be influenced by earnings results, analyst revisions, sector rotation, and broader market sentiment. Notable catalyst: Diversified exposure to aerospace, automotive, and medical industries.. Check the News and Technical Analysis tabs for the latest drivers. Past performance does not predict future results.
Should investors consider LSIIF overvalued or undervalued right now?
Determining whether Lisi S.A. (LSIIF) is overvalued or undervalued requires examining multiple metrics. Compare valuation ratios (P/E, P/S, EV/EBITDA) against sector peers for a comprehensive view.
What research should beginners do before buying LSIIF?
Before investing in Lisi S.A. (LSIIF), research these four areas: (1) the company's revenue model and competitive position (see Company Overview), (2) financial health through revenue growth, margins, and cash flow (see MoonshotScore), (3) what Wall Street analysts recommend and their price targets (see Analyst tab), and (4) specific risk factors that could impact the stock (see Risk Factors section).
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
Data provided for informational purposes only.
- Information is based on available data and may not be comprehensive.
- AI analysis is pending for LSIIF.